Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Neoplasms, Plasma Cell × Atorvastatin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 13 Prostatic Neoplasms 9 Neoplasms 4 Endometrial Neoplasms 3 Colonic Neoplasms 3 Cardiotoxicity 3 Triple Negative Breast Neoplasms 2 Rectal Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Polycystic Ovary Syndrome 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Myelodysplastic Syndromes 2 Leukemia, Myeloid, Acute 2 Heart Failure 2 Glioblastoma 2 Endometrial Hyperplasia 2 Colorectal Neoplasms 2 Cardiovascular Diseases 2 Venous Thrombosis 1 Smoking 1 Pulmonary Disease, Chronic Obstructive 1 Precancerous Conditions 1 Overall Survival 1 Ototoxicity 1 Neoplastic Cells, Circulating 1 Neoplasms, Plasma Cell 1 Nasopharyngeal Carcinoma 1 Melanoma 1

Interventions

Dexamethasone 97 Cyclophosphamide 86 Melphalan 78 Bortezomib 59 Peripheral Blood Stem Cell Transplantation 51 Lenalidomide 48 Busulfan 42 Filgrastim 41 fludarabine phosphate 40 Thalidomide 31 Radiotherapy 31 Antilymphocyte Serum 31 Tacrolimus 27 Mycophenolic Acid 22 fludarabine 21 Etoposide 21 Cyclosporine 21 Prednisone 20 Calcium Dobesilate 20 Methotrexate 19 Methylprednisolone 18 Whole-Body Irradiation 17 carfilzomib 16 pomalidomide 15 sargramostim 14 daratumumab 13 Granulocyte Colony-Stimulating Factor 13 Rituximab 12 Interferon-alpha 12 Carmustine 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00164086 2006-10-11

Atorvastatin in Myeloma

Bayside Health

Phase 1 Unknown

Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡